학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 47건 | 목록 1~20
Academic Journal
Pastoors D; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Smeenk L; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Ottema S; Department of Clinical Genetics, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Anthonissen M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Grob T; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Subramanian S; School of Clinical Medicine, University of New South Wales, Sydney, Australia.; Oregon Health & Science University, Portland, OR.; Thoms JAI; School of Biomedical Sciences, University of New South Wales, Sydney, Australia.; Pimanda JE; School of Biomedical Sciences, University of New South Wales, Sydney, Australia.; Department of Clinical Haematology, Prince of Wales Hospital, Sydney, Australia.; Wouters BJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Beverloo B; Department of Clinical Genetics, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Haferlach T; Munich Leukemia Laboratory, Munich, Germany.; Haferlach C; Munich Leukemia Laboratory, Munich, Germany.; Zuber J; Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.; Medical University of Vienna, Vienna BioCenter, Vienna, Austria.; Bindels E; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Ottema S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Arricibita Varea A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Vermeulen M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Beverloo HB; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Gröschel S; A380, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Haferlach T; Munich Leukemia Laboratory, Munich, Germany.; Haferlach C; Munich Leukemia Laboratory, Munich, Germany.; J Wouters B; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Bindels E; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Smeenk L; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. h.delwel@erasmusmc.nl.; Oncode Institute, Utrecht, The Netherlands. h.delwel@erasmusmc.nl.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Nuetzel M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Sijs-Szabo A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Díaz N; Max Planck Institute for Molecular Biomedicine, Muenster, Germany.; Renewable Marine Resources Department, Institute of Marine Sciences (ICM-CSIC), Barcelona, Spain.; Kelly K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Schwarzfischer-Pfeilschifter L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Stanewsky H; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Ackermann U; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Glatz D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Raithel J; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Fischer A; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Pohl S; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.; Department of Conservative Dentistry and Periodontology, University Hospital Regensburg, Regensburg, Germany.; Rijneveld A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vaquerizas JM; Max Planck Institute for Molecular Biomedicine, Muenster, Germany.; MRC London Institute of Medical Sciences, London, United Kingdom.; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital 8 Campus, London, United Kingdom.; Thiede C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wouters BJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. b.wouters@erasmusmc.nl.; Oncode Institute, Utrecht, the Netherlands. b.wouters@erasmusmc.nl.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. h.delwel@erasmusmc.nl.; Oncode Institute, Utrecht, the Netherlands. h.delwel@erasmusmc.nl.; Rehli M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. michael.rehli@klinik.uni-regensburg.de.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany. michael.rehli@klinik.uni-regensburg.de.; Gebhard C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. claudia.gebhard@klinik.uni-regensburg.de.; Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany. claudia.gebhard@klinik.uni-regensburg.de.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Jongen-Lavrencic, M, Grob, T, Hanekamp, D, Kavelaars, F G, Al Hinai, A, Zeilemaker, A, Erpelinck-Verschueren, C A J, Gradowska, P L, Meijer, R, Cloos, J, Biemond, B J, Graux, C, van Marwijk Kooy, M, Manz, M G, Pabst, T, Passweg, J R, Havelange, V, Ossenkoppele, G J, Sanders, M A, Schuurhuis, G J, Löwenberg, B & Valk, P J M 2018, 'Molecular Minimal Residual Disease in Acute Myeloid Leukemia', New England Journal of Medicine, vol. 378, no. 13, pp. 1189-1199. https://doi.org/10.1056/NEJMoa1716863
The New England journal of medicine, Vol. 378, no. 13, p. 1189-1199 (2018)
Jongen-Lavrencic, Mojca; Grob, Tim; Hanekamp, Diana; Kavelaars, François G; Al Hinai, Adil; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Gradowska, Patrycja L; Meijer, Rosa; Cloos, Jacqueline; Biemond, Bart J; Graux, Carlos; van Marwijk Kooy, Marinus; Manz, Markus G; Pabst Müller, Thomas Niklaus; Passweg, Jakob R; Havelange, Violaine; Ossenkoppele, Gert J; Sanders, Mathijs A; Schuurhuis, Gerrit J; ... (2018). Molecular Minimal Residual Disease in Acute Myeloid Leukemia. New England journal of medicine NEJM, 378(13), pp. 1189-1199. Massachusetts Medical Society MMS 10.1056/NEJMoa1716863
Academic Journal
Smeenk L; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Ottema S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Ebert A; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Havermans M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Varea AA; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Fellner M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Pastoors D; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Herk S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Grob T; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Hoogenboezem RM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Matson DR; Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, Wisconsin.; Bresnick EH; Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, Wisconsin.; Bindels EM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Kentsis A; Tow Center for Developmental Oncology, Sloan Kettering Institute, Department of Pediatrics, Weill Medical College of Cornell University, Memorial Sloan Kettering Cancer Center, New York, New York.; Zuber J; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.; Delwel R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. h.delwel@erasmusmc.nl.; Oncode Institute, Utrecht, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Erpelinck-Verschueren, C A J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어